SCHEMBL23090410

SCHEMBL23090410

CCc1cc2c(cc1C(=O)Nc1ccc(C(C)(C)C)cc1)CCCCC2

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 5/20 0.69
▸ TRPV1 Q8NER1 2/20 0.47
▸ PLG P00747 2/20 0.47
▸ KLK1 P06870 2/20 0.47
▸ KLK6 Q92876 2/20 0.47
▸ KLKB1 P03952 1/20 0.47
▸ NR1H4 Q96RI1 4/20 0.46
▸ LMNA P02545 3/20 0.46
▸ MAPT P10636 3/20 0.46
▸ SMN1; SMN2 Q16637 3/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ MAPK14 Q16539 1/20 0.45
▸ NPC1 O15118 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ HDAC3 O15379 1/20 0.45
▸ HDAC11 Q96DB2 1/20 0.45
▸ HDAC8 Q9BY41 1/20 0.45
▸ HDAC6 Q9UBN7 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23090370 0.85 DHODH (0.72) DHODHTRPV1PLGKLK1KLK6
SCHEMBL23105165 0.85 DHODH (0.72) DHODHTRPV1NR1H4LMNAMAPT
SCHEMBL23090405 0.83 DHODH (0.77) DHODHTRPV1PLGKLK1KLK6
SCHEMBL23090382 0.81 DHODH (1.00) DHODHTRPV1NR1H4LMNAMAPT
SCHEMBL23105331 0.79 DHODH (0.72) DHODHTRPV1PLGKLK1KLK6
SCHEMBL23090417 0.78 DHODH (0.62) DHODHTRPV1NR1H4LMNAMAPT
SCHEMBL23090389 0.78 DHODH (0.76) DHODHTRPV1PLGKLK1KLK6
SCHEMBL21468516 0.76 NPC1 (0.68) DHODHTRPV1LMNAMAPTSMN1; SMN2
SCHEMBL23090367 0.76 DHODH (1.00) DHODHNR1H4LMNAMAPTSMN1; SMN2
SCHEMBL23090408 0.75 DHODH (0.67) DHODHTRPV1NR1H4LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11066357-B2 Benzoannulene derivatives as antiviral agents SOUTHERN RESEARCH INSTITUTE (US) 2021-07-20 — — US disclosed
US-11066357-B2 Benzoannulene derivatives as antiviral agents SOUTHERN RESEARCH INSTITUTE (US) 2021-07-20 — — US disclosed
US-20210078937-A1 BENZOANNULENE DERIVATIVES AS ANTIVIRAL AGENTS SOUTHERN RESEARCH INSTITUTE 2021-03-18 — — US disclosed
US-20210078937-A1 BENZOANNULENE DERIVATIVES AS ANTIVIRAL AGENTS SOUTHERN RESEARCH INSTITUTE 2021-03-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210078937-A1 BENZOANNULENE DERIVATIVES AS ANTIVIRAL AGENTS ZC3HAV1, MAVS, ZC3HAV1L DHODH 344/4885TRPV1 2296/4885PLG 4498/4885
US-11066357-B2 Benzoannulene derivatives as antiviral agents ZC3HAV1, MAVS, ZC3HAV1L DHODH 344/4885TRPV1 2296/4885PLG 4498/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback